Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Pathology

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)64123-5PMID 11337365PMCID PMC1891939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis

  2004cited by this paper
• Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

  2001cited by this paper
• Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation

  2000cited by this paper
• Ductal lesions in patients with chronic pancreatitis show K‐ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53

  2000cited by this paper
• Genetic progression and divergence in pancreatic carcinoma.

  2000influential reference
• Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

  2000cited by this paper
• Genetic progression in the pancreatic ducts.

  2000cited by this paper
• Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

  2000cited by this paper
• Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.

  2000cited by this paper
• The K‐ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium

  1999cited by this paper
• Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution

  1999cited by this paper
• Loss of chromosome 18q is an early event in pancreatic ductal tumorigenesis.

  1998cited by this paper
• Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

  1998cited by this paper
• p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

  1997cited by this paper
• K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers

  1997cited by this paper
• Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA.

  1996cited by this paper
• p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

  1994cited by this paper
• Overexpression of p53 protein in adenocarcinoma of the pancreas.

  1994cited by this paper
• Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas.

  1994cited by this paper
• p53 and K-RAS alterations in pancreatic epithelial cell lesions.

  1993cited by this paper
• Relation of pancreatic duct hyperplasia to carcinoma

  1979cited by this paper
• Morphological lesions associated with human primary invasive nonendocrine pancreas cancer.

  1976cited by this paper

• Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesis

  2025cites this paper
• From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression.

  2024cites this paper
• Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO

  2024cites this paper
• Drug-Induced p53 Activation Limits Pancreatic Cancer Initiation

  2024cites this paper
• Analytical Validation of Loss of Heterozygosity and Mutation Detection in Pancreatic Fine-Needle Aspirates by Capillary Electrophoresis and Sanger Sequencing

  2024cites this paper
• Gradual transition towards anaplasia in Wilms tumor through tolerance to genetic damage.

  2023cites this paper
• KLF6 Mediates de novo Ornithine Synthesis and Polyamine Production in Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma.

  2023cites this paper
• Multifaceted role for p53 in pancreatic cancer suppression

  2023cites this paper
• Concurrent activation of Kras and canonical Wnt signaling induces premalignant lesions that progress to extrahepatic biliary cancer in mice.

  2022cites this paper
• Loss of tumor suppressor WWOX enhances RAS activity in pancreatic cancer

  2022cites this paper
• The molecular landscape of pancreatic ductal adenocarcinoma.

  2022cites this paper
• Recurrent driver mutations in benign tumors.

  2022cites this paper
• mAb Das-1 Identifies Pancreatic Ductal Adenocarcinoma and High-grade Pancreatic Intraepithelial Neoplasia with High Accuracy.

  2021cites this paper
• Precision Medicine and Pancreatic Cancer.

  2021cites this paper
• Intraduktale Pankreasneoplasien

  2021cites this paper
• Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer

  2021cites this paper
• Pancreatic cancer.

  2021cites this paper
• promotes mevalonate pathway dependency in pancreatic cancer.

  2020cites this paper
• SOAT1 promotes mevalonate pathway dependency in pancreatic cancer

  2020cites this paper
• Solide und zystische nichtendokrine Tumoren des Pankreas

  2020cites this paper
• Targeting the Epigenome as a Therapeutic Strategy for Pancreatic Tumors: DNA and Histone Modifying Enzymes

  2019cites this paper
• Genetics of Familial and Sporadic Pancreatic Cancer.

  2019cites this paper
• The leukocyte complexity and mutational landscape of periampullary adenocarcinoma. Morphology matters.

  2019cites this paper
• Molecular Profiling in Pancreatic Ductal Adenocarcinoma

  2019cites this paper
• Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.

  2019cites this paper
• The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility

  2019cites this paper
• Age‐related morphological changes in the pancreas and their association with pancreatic carcinogenesis

  2019cites this paper
• The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA

  2019cites this paper
• Telomere length determined by the fluorescence in situ hybridisation distinguishes malignant and benign cells in cytological specimens

  2018cites this paper
• Pancreas and Biliary Tract

  2018cites this paper
• From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions

  2018influential citation
• Precursor Lesions of Pancreatic Cancer

  2018cites this paper
• Pancreatic Cancer: Precancerous Lesions

  2018cites this paper
• Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma

  2018cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• High‐grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer

  2018influential citation
• Role of gata4 in pancreatic physiology and carcinogenesis

  2017cites this paper
• BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.

  2017cites this paper
• CD47+ Exosomes Facilitate Effective Targeting of Oncogenic Kras in Pancreatic Cancer

  2017cites this paper
• The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer

  2017cites this paper
• Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions: Systematic Pathologic Studies of 165 Cases

  2017cites this paper
• A genetic roadmap of pancreatic cancer: still evolving

  2017cites this paper
• Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest

  2017cites this paper
• A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer.

  2017cites this paper
• A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns

  2016cites this paper
• Molecular Genetics of Pancreatic Neoplasms.

  2016cites this paper
• Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.

  2016cites this paper
• Pathology of Pancreatic Cancer Precursor Lesions.

  2016cites this paper
• Epithelial to Mesenchymal Transition and the generation of stem-like cells in companion animal breast cancer

  2016cites this paper
• Molecular analysis of mucinous nonneoplastic cyst of the pancreas.

  2016cites this paper
• Análisis de la heterogeneidad genética del adenocarcinoma ductal de páncreas y su relación con las características de la enfermedad

  2015influential citation
• Next-generation genetically engineered mouse models to study PI3K/3-phosphoinositide-dependent protein kinase 1 (Pdk1) signaling in pancreatic cancer

  2015cites this paper
• Gradual Telomere Shortening and Increasing Chromosomal Instability among PanIN Grades and Normal Ductal Epithelia with and without Cancer in the Pancreas

  2015cites this paper
• Transforming Growth Factor-beta Superfamily in Meningiomas: Targets for Novel Therapy in eningiomas

  2015cites this paper
• The genetic classification of pancreatic neoplasia

  2015cites this paper
• Pancreatic adenocarcinoma pathology: changing "landscape".

  2015cites this paper
• Genomic alterations in pancreatic cancer and their relevance to therapy.

  2015cites this paper
• Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update.

  2015cites this paper
• Genomic medicine for cancer prognosis

  2015cites this paper
• Utility of immunohistochemistry in the pancreatobiliary tract.

  2015cites this paper
• Molecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non-neoplastic nature

  2014cites this paper
• Frequency of Kras Mutations in Pancreatic Intraductal Neoplasias Associated with Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis : A Meta-Analysis 1

  2014cites this paper
• Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression.

  2014cites this paper
• MicroRNA modulation in combination with chemotherapeutic drugs as a novel therapeutic strategy for pancreatic cancer

  2014cites this paper
• Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer

  2014cites this paper
• Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.

  2014cites this paper
• Molecular pathology of pancreatic cancer

  2014cites this paper
• Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

  2014cites this paper
• Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas.

  2014cites this paper
• Early detection and prevention of pancreatic cancer: is it really possible today?

  2014cites this paper
• Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications.

  2014cites this paper
• Pancreatic cancer genomics: insights and opportunities for clinical translation

  2013cites this paper
• MicroRNAs em adenocarcinoma ductal pancreático : novos biomarcadores de diagnóstico e prognóstico

  2013cites this paper
• Desmoplastic stromal cells modulate tumour cell behaviour in pancreatic cancer

  2013cites this paper
• The Role of Non-cancerous Cells in Cancer: Pancreatic Ductal Adenocarcinoma as a Model to Understand the Impact of Tumor Microenvironment on Epithelial Carcinogenesis

  2013cites this paper
• Identification and analysis of precursors to invasive pancreatic cancer.

  2013cites this paper
• Genomic Alterations in Sporadic Pancreatic Cancer

  2013cites this paper
• Molecular Pathology of Pancreatic Cancer Precursor Lesions

  2013cites this paper
• Genome-Wide Somatic Copy Number Alterations in Low-Grade PanINs and IPMNs from Individuals with a Family History of Pancreatic Cancer

  2012cites this paper
• An investigation of the prognostic value of pathological and genomic factors in pancreatic ductal adenocarcinoma

  2012influential citation
• Tumor suppressor genes

  2012cites this paper
• Identifying genes that are required for the maintenance of pancreatic ductal adenocarcinoma

  2012cites this paper
• Alterations in the Smad pathway in human cancers.

  2012cites this paper
• Pancreatic cancer and premalignant tumors: Molecular aspects

  2012cites this paper
• Two sides of the story? Smad4 loss in pancreatic cancer versus head‐and‐neck cancer

  2012cites this paper
• Signaling Mechanisms of Transforming Growth Factor-β (TGF-β) in Cancer: TGF-β Induces Apoptosis in Lung Cells by a Smad-Dependent Mechanism

  2012cites this paper
• Expression of von Hippel-Lindau gene product (pVHL) and S100P in cystic neoplasms of the pancreas--with an implication for their roles in tumorigenesis.

  2012cites this paper
• Pathology and Molecular Genetics of Pancreatic Neoplasms

  2012cites this paper
• Signaling Cross-Talk of Oncogenic KRAS and Hedgehog Pathways in Pancreatic Cancer

  2011cites this paper
• Pathophysiology of pancreatic cancer

  2011cites this paper
• Pancreatic Intraepithelial Neoplasia.

  2011cites this paper
• Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions.

  2011cites this paper
• Precursor Lesions of Pancreatic Cancer

  2011cites this paper
• p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells

  2011cites this paper
• ABERRATIONS OF A PUTATIVE TUMOR SUPPRESSOR GENE SEL1L IN PANCREATIC DUCTAL ADENOCARCINOMA

  2011cites this paper
• Genetically Engineered Mouse Models of Pancreatic Ductal Adenocarcinoma

  2011cites this paper
• Precursor lesions in pancreatic cancer: morphological and molecular pathology

  2011cites this paper
• MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer.

  2011cites this paper
• Molecular mechanism of parenchymal injury and the role of duct obstruction and ductal hypertension in the pathogenesis of chronic pancreatitis

  2011cites this paper